Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetes
Title:
Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetes
Author:
Yoon, Jongmin Lee, Don-Gil Song, Haengjin Hong, Dahae Park, Ji Soo Hong, Changhee An, Kyung Mi Lee, Jung Woo Park, Joon-Tae Yoon, Hongchul Tak, Jihoon Kim, Sang Geon